Eurofarma Innovation and Growth Strategy
5
EUROFARMA AT GLANCE
One of the Leading LatAm Pharma Company
50
Years
of history
++
1
Products in the pharma'
~8,000 employees
#1 prescription
#3 pharma
main segments
in Brazil and abroad
pharma in Brazil¹
in Brazil²
LEADERSHIP
Eurofarma
COMPETITIVENESS
sales force
+3,000 salespeople
27.3%
2021 Adjusted EBITDA margin
R$1.9 bi
#
2021 Adjusted EBITDA4
26% CAGR
2017-2021
www
EXPANSION
20 countries
presence
100%
LatAm coverage
eurofarma
#2 pharma
in LatAm³
INNOVATION
+300 projects
on pipeline
R$363 mm
R&D Expenses in 2021
RECOGNITION
18 years Great Place to
Work
4x Sustainability Ranking5
(the only pharma company)
(1) Eurofarma, Momenta and Supera; Close-up Jun/2022; (2) IQVIA: Retail Reais PPP/NRA Reais PP (Total Pharmaceutical Market, excluding Covid-19 vaccines) Jun/22; (3) Excluding multinational pharma companies not based in LatAm; (4) Adjusted for R&D expenses; (5) Guia Exame Award.View entire presentation